Staff Members - Benha University
Safety and efficacy outcomes of a novel hysterosacropexy: A fertility sparing, uterine preserving pelvic organ prolapse surgery
Evidence Based Women's Health Journal • 2018
Publication Information
Authors
Ashraf Nassif Mahmoud Elmantwe, Mohamed Anwar Elnory
Keywords
Cervico-sacropexy(CESA), CESA DynaMesh, hysterosacropexy, polyvinylidene fluoride (PVDF), spinal
anesthesia
Journal
Evidence Based Women's Health Journal
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Open Link
Supplementary Materials
Not Available
Abstract
Objective: To access the safety and efficacy outcomes of a new abdominal Hysterosacopexy with CESA (Cervicosacropexy) DynaMesh kit in treating advanced uterovaginal prolapse in young women aiming in uterine preservation
pelvic organ prolapse (POP) surgery.
Patients and Methods: Prospective nonrandomized controlled clinical trial enrolled consecutive women attending the
gynecology and obstetrics Department, Benha University Hospital for treatment of POP of stage II or greater on POP
quantification (POPQ) system on the apical domain. Participants underwent abdominal hysterosacropexy utilizing CESA
mesh kit of DynaMesh. POPQ staging, women symptoms, and quality of life were evaluated before and after surgery, as
well as surgery-related morbidity.
Results: The current study enrolled 20 women, all women were followed up for a period of 18 months postoperatively.
Significant post-surgical anatomical success was recorded across both POPQ anterior (point Aa, Ba) (P ≤ 0.0001,
P ≤ 0.0001), apical (point c, d) (P ≤ 0.0001, P≤ 0.0001) and Posterior (point Ap, Bp) (P ≤ 0.0001, P≤ 0.0001) domains.
Significant post-surgical functional improvements were recorded across prolapse symptoms, (bulge symptoms, overactive
bladder, stress urinary incontinence, bowel dysfunction, sexual dysfunction) (P ≤ 0.0001, P = 0.0064, P = 0.03,
P = 0.008, P ≤ 0.0001) respectively. ICIQ-VS (VS – SS – QOL) score (P≤ 0.0001, P ≤ 0.0001, P ≤ 0.0001). ICIQ – UI
– SF score (P ≤ 0.0001). No major complications occurred. No mesh erosions were reported.
Conclusion: Abdominal hysterosacropexy with CESA DynaMesh kit seems to be a safe and effective option for women
with advanced uterovaginal prolapse aiming for uterine preserving POP surgery.
pelvic organ prolapse (POP) surgery.
Patients and Methods: Prospective nonrandomized controlled clinical trial enrolled consecutive women attending the
gynecology and obstetrics Department, Benha University Hospital for treatment of POP of stage II or greater on POP
quantification (POPQ) system on the apical domain. Participants underwent abdominal hysterosacropexy utilizing CESA
mesh kit of DynaMesh. POPQ staging, women symptoms, and quality of life were evaluated before and after surgery, as
well as surgery-related morbidity.
Results: The current study enrolled 20 women, all women were followed up for a period of 18 months postoperatively.
Significant post-surgical anatomical success was recorded across both POPQ anterior (point Aa, Ba) (P ≤ 0.0001,
P ≤ 0.0001), apical (point c, d) (P ≤ 0.0001, P≤ 0.0001) and Posterior (point Ap, Bp) (P ≤ 0.0001, P≤ 0.0001) domains.
Significant post-surgical functional improvements were recorded across prolapse symptoms, (bulge symptoms, overactive
bladder, stress urinary incontinence, bowel dysfunction, sexual dysfunction) (P ≤ 0.0001, P = 0.0064, P = 0.03,
P = 0.008, P ≤ 0.0001) respectively. ICIQ-VS (VS – SS – QOL) score (P≤ 0.0001, P ≤ 0.0001, P ≤ 0.0001). ICIQ – UI
– SF score (P ≤ 0.0001). No major complications occurred. No mesh erosions were reported.
Conclusion: Abdominal hysterosacropexy with CESA DynaMesh kit seems to be a safe and effective option for women
with advanced uterovaginal prolapse aiming for uterine preserving POP surgery.